Altman Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,831
Closed -$808K 81
2020
Q3
$808K Buy
4,831
+252
+6% +$42.4K 0.57% 64
2020
Q2
$744K Buy
4,579
+205
+5% +$36.7K 0.63% 60
2020
Q1
$756K Sell
4,374
-168
-4% -$33.4K 0.7% 64
2019
Q4
$912K Buy
4,542
+8
+0.2% +$1.64K 0.73% 52
2019
Q3
$958K Buy
4,534
+178
+4% +$37.2K 0.81% 52
2019
Q2
$846K Buy
+4,356
New +$803K 0.71% 56
2018
Q3
Sell
-27,102
Closed -$1.81K 70
2018
Q2
$1.81K Buy
+27,102
New +$4.43M 1.67% 33

Other funds holding CME

Altman Advisors's CME Position: Q4 2020 in Review

Altman Advisors sold out of CME Group (CME) in Q4 2020, closing a stake of 4,831 shares — an estimated $808K sold.

Altman Advisors first reported a position in CME in Q2 2018 and held it in 7 quarters. The position peaked at $958K in Q3 2019. 1,030 funds tracked by Wall St. Rank hold CME as of Q4 2020.

  • Altman Advisors reported no remaining CME Group position as of Q4 2020 after selling out during the quarter.
  • Altman Advisors sold 4,831 CME Group shares in Q4 2020, an estimated $808K.
  • Altman Advisors first reported a position in CME Group in Q2 2018 and held it in 7 quarters.
  • Altman Advisors's CME Group position peaked at $958K in Q3 2019.
  • 1,030 funds tracked by Wall St. Rank held CME Group as of Q4 2020.

Based on Altman Advisors's 13F filing for Q4 2020, filed 10 Feb 2021.